CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Olainfarm AS is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Olainfarm AS
5 Rupnicu Street
Phone: +371 67013705p:+371 67013705 Olaine, 2114  Latvia Fax: +371 67013777f:+371 67013777

This company is no longer actively traded on any major stock exchange.

Business Summary
Olainfarm AS is a Latvia-based company engaged in the pharmaceutical sector. The Company is active in the production of basic pharmaceutical products and pharmaceutical preparations. The Company’s activities include numerous finished forms of medicaments with effects, which include cardiological, neurologic, diuretic, spasmologic and antiallergic drug preparations, medicaments treating the digestive system, antibiotics and food supplements, as well as various active chemical ingredients and raw chemical materials. Its products include Amlodipine, Clonazepam, Euphillin, Furosemide, Furagin, Midolat, Protionol and Gripoflex, among others. The Company operates through its subsidiaries which includes Reinolds SIA, Ozols JDR SIA, Olainfarm energija SIA, Ilmas Aptiekas SIA and Veritas-Farm, among others. In addition, the Company has 33 pharmacies, located in Riga, Vidzeme, Kurzeme and Latgale. In May 2013, it acquired a 47.5% shares in pharmaceutical manufacturer SIA Silvanols.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202112/31/2020Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Supervisory Council GundarsBerzins 4/1/2019 4/1/2019
Chairman of the Management Board JeroenWeites 11/28/2019 11/28/2019
Chief Executive Officer, Member of the Management Board ElenaBushberg 12/5/2019 12/5/2019
10 additional Officers and Directors records available in full report.

Business Names
Business Name
Olainfarm AS
OLF1R
SIA Ilmas aptiekas
4 additional Business Names available in full report.

General Information
Number of Employees: 2,191 (As of 12/31/2020)
Outstanding Shares: 14,085,078 (As of 9/30/2021)
Stock Exchange: RSE
Fax Number: +371 67013777
Email Address: olainfarm@olainfarm.com


Copyright © 2022 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, June 24, 2022